Actively Recruiting
Small Bowel Capsule Endoscopy in Lynch Syndrome
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-03-16
400
Participants Needed
1
Research Sites
76 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The impact of small bowel (SB) capsule endoscopy (CE) on the screening (followed by diagnosis and treatment) of (pre)neoplastic lesions of the small bowel in Lynch syndrome (LS) patients is unknown. The iCARE4Lynch study is a retrospective cohort of patients carrying a pathogenic variant of the DNA mismatch repair gene (MMR) (MLH1, MSH2, MSH6, PMS2, EPCAM) who had had at least one SBCE for screening of small bowel (pre)neoplastic lesions between January 1st 2000 and December 31 2024.
CONDITIONS
Official Title
Small Bowel Capsule Endoscopy in Lynch Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient carrying a pathogenic variant of the DNA mismatch repair gene (MMR) (MLH1, MSH2, MSH6, PMS2, EPCAM)
- Capsule endoscopy screening for (pre)neoplastic lesions of the small intestine
- No opposition to the reuse of healthcare data for research purposes
You will not qualify if you...
- Absence of documented MMR gene variant
- Opposition to the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Center for Digestive Endoscopy, Saint-Antoine Hospital
Paris, France
Actively Recruiting
Research Team
X
Xavier DRAY, MD PhD
CONTACT
A
Aymeric BECQ, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here